Simplex Trading’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Simplex Trading’s Portfolio LHDX Stock Details LHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-28,200	Closed	-$6K	–	10469
2023 Q1	$6K	Buy	+28,200	New	+$10K	﹤0.01%	7990
2022 Q3	–	Sell	-7,300	Closed	-$13K	–	11312
2022 Q2	$13K	Sell	7,300 -1,400	-16%	-$3.4K	﹤0.01%	8089
2022 Q1	$31K	Sell	8,700 -900	-9%	-$4.42K	﹤0.01%	7753
2021 Q4	$82K	Buy	9,600 +7,700	+405%	+$49K	﹤0.01%	6555
2021 Q3	$11K	Hold	1,900	–	–	﹤0.01%	8901
2021 Q2	$12K	Buy	+1,900	New	+$12K	﹤0.01%	9011

Other funds holding LHDX

Resolute Advisors San Francisco, California $242M AUM 52.95% 1-Year Est. Return

Simplex Trading's LHDX Position: Q2 2023 in Review

Simplex Trading sold out of Lucira Health, Inc. Common Stock (LHDX) in Q2 2023, closing a stake of 74,764 shares — an estimated $17K sold.

Simplex Trading first reported a position in LHDX in Q2 2021 and held it in 8 quarters. The position peaked at $524K in Q4 2021. 1 fund tracked by Wall St. Rank holds LHDX as of Q2 2023.

Simplex Trading reported no remaining Lucira Health, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Simplex Trading sold 74,764 Lucira Health, Inc. Common Stock shares in Q2 2023, an estimated $17K.
Simplex Trading first reported a position in Lucira Health, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
Simplex Trading's Lucira Health, Inc. Common Stock position peaked at $524K in Q4 2021.
1 fund tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.